Evidence map›Paper›PMID 35637321›Full record

ArticleAntonie van Leeuwenhoek2022

Diversity of the culturable lichen-derived actinobacteria and the taxonomy of Streptomyces parmotrematis sp. nov.

Achiraya Somphong, Vasun Poengsungnoen, Kawinnat Buaruang, Chanwit Suriyachadkun, Paranee Sripreechasak, Somboon Tanasupawat, Wongsakorn Phongsopitanun

Abstract read
PubMed Publisher
In one paragraph

Article in Antonie van Leeuwenhoek, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Antibiotics (Basel, Switzerland) · 2023
    Article
  5. Lichen-Derived Actinomycetota: Novel Taxa and Bioactive Metabolites.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Achiraya SomphongDepartment of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.
Vasun PoengsungnoenLichen Research Unit, Department of Biology, Faculty of Science, Ramkhamhaeng University, Bangkok, 10240, Thailand.
Kawinnat BuaruangLichen Research Unit, Department of Biology, Faculty of Science, Ramkhamhaeng University, Bangkok, 10240, Thailand.
Chanwit SuriyachadkunNational Center for Genetic Engineering and Biotechnology (BIOTEC), Thailand Science Park, Pathumthani, 12120, Thailand.
Paranee SripreechasakDepartment of Biotechnology, Faculty of Science, Burapha University, Chonburi, 20131, Thailand.
Somboon TanasupawatDepartment of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.
Wongsakorn PhongsopitanunDepartment of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand. Wongsakorn.p@chula.ac.th.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A total of 37 actinobacteria were isolated from eighteen lichen samples collected in Thailand. Based on the 16S rRNA gene sequences, they were identified into five genera including Actinoplanes (1 strain), Actinomadura (1 strain), Pseudosporangium (1 strain), Wangella (1 strain) and Streptomyces (33 strains). Among these isolates, strain Ptm05

Indexed as

ActinobacteriaLichensStreptomycesBacterial Typing TechniquesBase CompositionDNA, BacterialFatty AcidsPhospholipidsPhylogenyRNA, Ribosomal, 16SSequence Analysis, DNASoil MicrobiologyDNA, BacterialFatty AcidsPhospholipidsRNA, Ribosomal, 16SActinobacteriaActinomycetesLichenParmotremaStreptomyces parmotrematis

Identifiers

PMID35637321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.